DTaP "INFANRIX" POST MARKET ADVERSE REACTIONS


DTaP "INFANRIX" made by vaccine manufacturer GlaxoSmithKline. On this page you will see the POST MARKET Adverse Reactions listed on the Manufacturers Insert (that you do not receive)


* These adverse events were reported voluntarily from a population of uncertain size; therefore, it is not always possible to reliably estimate their frequency or establish a causal relationship to vaccination.

INFECTIONS AND INFESTATIONS

1. Bronchitis (Inflammation of bronchial tubes)

2. Cellulitis (A serious bacterial infection of the skin)

3. Respiratory Tract Infection (infection: sinuses, throat, airways or lungs)

BLOOD AND LYMPHATIC SYSTEM DISORDER

1. Lymphadenopathy (Swollen lymph nodes)

2. Thrombocytopenia (low blood platelet count)

IMMUNE SYSTEM DISORDERS

1. Anaphylactic Reaction (A life-threatening allergic reaction)

2. Hypersensitivity (an over-reaction of the immune system)

NERVOUS SYSTEM DISORDERS

1. Encephalopathy (a syndrome of overall brain dysfunction)

2. Headache

3. Hypotonia ("floppy baby syndrome", is a state of low muscle tone)

4. Syncope (Fainting, sudden temporary loss of consciousness)

EAR AND LABYRINTH DISORDERS

1. Ear pain

CARDIAC DISORDERS

1. Cyanosis (blue or purple coloration of the skin from low oxygen)

RESPIRATORY, THORACIC AND MEDIASTINAL DISORDERS

1. Apnea (suspension of breathing)

2. Cough

SKIN AND SUBCUTANEOUS TISSUE DISORDERS

1. Angioedema (swelling of the lower layer of skin and tissue)

2. Erythema (redness of the skin)

3. Pruritus (Itchy skin)

4. Rash

5. Urticaria (Hives)

GENERAL DISORDERS AND ADMINISTRATION SITE CONDITIONS

51. Fatigue

2. Injection Site Induration (skin becomes hard)

3. Injection Site Reaction

4. Sudden Infant Death Syndrome (SIDS)